Moleculin Biotech Files $75 Million Mixed Shelf - (Fidelity via NewsPoints Desk)

  • Moleculin Biotech filed a shelf registration statement for the sale of up to $75 million of securities from time to time, as reported in Fidelity.

  • The company expects to use the net proceeds for clinical trials, if any, as well as preclinical programs and other R&D activities.

To read more NewsPoints articles, click here.